Feb 26, 2026 07:00AM
Jan 6, 2026 07:30AM
Jan 6, 2026 07:30AM
Nov 6, 2025 07:00AM
Oct 24, 2025 09:00AM
Oct 24, 2025 09:00AM
Oct 13, 2025 12:02PM Zai Lab to present updated data on lung cancer drug at 2025 conference
Oct 13, 2025 12:02PM
Sep 2, 2025 05:01AM
Sep 1, 2025 08:00PM
Aug 7, 2025 06:00AM
Jun 2, 2025 07:01AM
Jun 2, 2025 07:00AM
May 31, 2025 03:08PM Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
May 19, 2025 07:02AM
May 19, 2025 07:00AM
May 8, 2025 06:00AM
Apr 23, 2025 10:56AM
Apr 21, 2025 07:30AM
Apr 21, 2025 07:30AM
Mar 12, 2025 07:30PM Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer
Feb 27, 2025 06:00AM
Jan 22, 2025 11:16PM
Jan 22, 2025 11:15PM
Jan 17, 2025 07:30AM
Jan 17, 2025 07:30AM
Jan 15, 2025 07:30AM
Jan 15, 2025 07:30AM Zai Lab Announces Positive Topline Results for TIVDAK in the China Subpopulation of the Global Phase 3 innovaTV 301 Trial in Patients with Recurrent or Metastatic Cervical Cancer
Nov 27, 2024 11:05PM
Nov 21, 2024 04:00AM
Nov 12, 2024 06:30AM
Sep 27, 2024 08:05AM
Aug 6, 2024 04:05PM
Jul 16, 2024 12:15AM
May 20, 2024 05:54AM Zai Lab Limited (ZLAB) and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO
May 20, 2024 12:21AM
May 13, 2024 05:47AM
May 12, 2024 08:20PM
May 8, 2024 04:05PM
Apr 1, 2024 07:31AM
Apr 1, 2024 07:30AM
Feb 27, 2024 04:05PM Zai Lab Announces Full-Year 2023 Financial Results and Recent Corporate Updates
Jan 10, 2024 05:12PM
Jan 10, 2024 05:12PM
Dec 13, 2023 08:53AM
Nov 7, 2023 04:05PM
Jul 26, 2023 09:00PM
Jul 21, 2023 09:00PM
Jul 16, 2023 09:00PM Bragar Eagel & Squire, P.C. Is Investigating Xponential, Franchise Group, Zai Lab, and Alvotech and Encourages Investors to Contact the Firm
Jul 10, 2023 09:39PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All